These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6672795)

  • 21. Neurotensin increases the cationic conductance of rat substantia nigra dopaminergic neurons through the inositol 1,4,5-trisphosphate-calcium pathway.
    Wu T; Li A; Wang HL
    Brain Res; 1995 Jun; 683(2):242-50. PubMed ID: 7552360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein kinase C mediates neurotensin inhibition of inwardly rectifying potassium currents in rat substantia nigra dopaminergic neurons.
    Wu T; Wang HL
    Neurosci Lett; 1995 Jan; 184(2):121-4. PubMed ID: 7724045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats.
    Santiago M; Westerink BH
    J Neurochem; 1991 Sep; 57(3):738-47. PubMed ID: 1677674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacology of neurotensin analogues on neurones in the rat substantia nigra, pars compacta in vitro.
    Keegan KD; Woodruff GN; Pinnock RD
    Eur J Pharmacol; 1994 Feb; 253(1-2):131-7. PubMed ID: 8013539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous comparison of cerebral dialysis and push-pull perfusion in the brain of rats: a critical review.
    Myers RD; Adell A; Lankford MF
    Neurosci Biobehav Rev; 1998 May; 22(3):371-87. PubMed ID: 9579326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of d-amphetamine on dopaminergic neurotransmission; a comparison between the substantia nigra and the striatum.
    Elverfors A; Nissbrandt H
    Neuropharmacology; 1992 Jul; 31(7):661-70. PubMed ID: 1328918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Sirinathsinghji DJ; Whittington PE; Audsley AR
    Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis.
    Fuxe K; Janson AM; Rosén L; Finnman UB; Tanganelli S; Morari M; Goldstein M; Agnati LF
    Exp Brain Res; 1992; 88(1):117-30. PubMed ID: 1347270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo presynaptic control of dopamine release in the cat caudate nucleus--I. Opposite changes in neuronal activity and release evoked from thalamic motor nuclei.
    Romo R; Chéramy A; Godeheu G; Glowinski J
    Neuroscience; 1986 Dec; 19(4):1067-79. PubMed ID: 3029624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reserpine-insensitive dopamine release in the substantia nigra?
    Elverfors A; Nissbrandt H
    Brain Res; 1991 Aug; 557(1-2):5-12. PubMed ID: 1720998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disulfiram alters dopamine metabolism at sites in rat's forebrain as detected by push-pull perfusions.
    Weiner H; Simpson CW; Thurman JA; Myers RD
    Brain Res Bull; 1978; 3(5):541-8. PubMed ID: 122719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kainic acid-induced changes of serotonin and dopamine metabolism in the striatum and substantia nigra of the rat.
    Sperk G; Berger M; Hörtnagl H; Hornykiewicz O
    Eur J Pharmacol; 1981 Sep; 74(4):279-86. PubMed ID: 6170518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo neurochemical analysis, by push-pull perfusion, of the mesocortical dopaminergic system of the rat during self-stimulation.
    Myers RD; Mora F
    Brain Res Bull; 1977; 2(2):105-12. PubMed ID: 880482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biotransformation of L-DOPA to dopamine in the substantia nigra of freely moving rats: effect of dopamine receptor agonists and antagonists.
    Sarre S; Vandeneede D; Ebinger G; Michotte Y
    J Neurochem; 1998 Apr; 70(4):1730-9. PubMed ID: 9523592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced response to the inhibitory action of LY171555, a dopamine D2-agonist, on in vivo striatal dopamine release in DOCA/NaCl-hypertensive rats.
    Chen YF; Oparil S
    Brain Res; 1987 Jan; 400(2):225-31. PubMed ID: 2949797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute effects of intranigral application of MPP+ on nigral and bilateral striatal release of dopamine simultaneously recorded by microdialysis.
    Santiago M; Rollema H; de Vries JB; Westerink BH
    Brain Res; 1991 Jan; 538(2):226-30. PubMed ID: 1707325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys.
    Gerhardt GA; Cass WA; Huettl P; Brock S; Zhang Z; Gash DM
    Brain Res; 1999 Jan; 817(1-2):163-71. PubMed ID: 9889359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specificity of GABA as a stimulator of dopamine release in rat substantia nigra.
    Starr MS
    Neurosci Lett; 1980 May; 18(1):79-84. PubMed ID: 6133247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of dendritic release of dopamine by N-methyl-D-aspartate receptors in rat substantia nigra.
    Araneda R; Bustos G
    J Neurochem; 1989 Mar; 52(3):962-70. PubMed ID: 2563759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo neurochemical and behavioural effects of intracerebrally administered neurotensin and D-Trp11-neurotensin on mesolimbic and nigrostriatal dopaminergic function in the rat.
    Ford AP; Marsden CA
    Brain Res; 1990 Nov; 534(1-2):243-50. PubMed ID: 2073584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.